Ullah · Life sciences 2025 · In vitro comparative laboratory study · n=?

Epitalon-activated telomerase enhance bovine oocyte maturation rate and post-thawed embryo development.

Cited 4 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

In vitro bovine laboratory study with no human data

PubMed 39788414 · doi:10.1016/j.lfs.2025.123381 · record verified 2026-08-27

What was done

Researchers evaluated telomerase protein levels and localization in healthy versus degraded bovine cumulus-oocyte complexes using immunofluorescence assays. They then assessed the effect of activating telomerase using Epitalon (a tetrapeptide: Ala-Glu-Asp-Gly) during in vitro embryo production. Measured outcomes included oocyte maturation rate, post-thaw blastocyst hatching rate, and implantation potential. Additionally, qPCR, reactive oxygen species (ROS) assays, and JC-1 mitochondrial membrane potential assays were performed on mature oocytes, cumulus cells, and post-thawed blastocysts.

What was found

Healthy cumulus-oocyte complexes displayed nuclear localization of telomerase, whereas degraded complexes showed reduced levels localized to the cytoplasm. Post-thaw embryos exhibited compromised telomerase activity. Epitalon treatment significantly increased oocyte maturation rate compared to controls (p < 0.05) and significantly improved post-thawed blastocyst hatching rate and implantation potential (p < 0.05). qPCR, ROS, and JC-1 assays demonstrated improvements in cellular and mitochondrial health markers, though specific numerical values and effect sizes were not reported in the abstract.

Why it matters

The findings suggest that telomerase activation by Epitalon may counteract in vitro culture and cryopreservation stress, providing a potential strategy to optimize bovine assisted reproductive technologies.

Limits

The study is restricted to in vitro bovine cells and embryos, with no in vivo fertility, pregnancy, or live-birth verification. Exact sample sizes (number of oocytes/embryos), peptide concentrations, and numerical baseline/post-treatment values were omitted from the abstract. Results cannot be directly generalized to human reproductive medicine.

Cited by